Gadoversetamide

Gadoversetamide
Clinical data


AHFS/Drugs.com	Micromedex Detailed Consumer Information
Pregnancy category	US: C (Risk not ruled out)
Routes of administration	Intravenous
ATC code	V08CA06 (WHO)
Pharmacokinetic data
Protein binding	Nil
Metabolism	Nil
Biological half-life	80 to 120 minutes
Excretion	Renal
Identifiers
CAS Number	131069-91-5^Y
PubChem CID	6435809
DrugBank	DB00538^Y
ChemSpider	392041^Y
UNII	RLM74T3Z9D
KEGG	D01646^Y
ChEMBL	CHEMBL1200457^N
Chemical and physical data
Formula	C₂₀H₃₄GdN₅O₁₀
Molar mass	661.77 g/mol
3D model (Jmol)	Interactive image
SMILES [Gd+3].O=C(NCCOC)CN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC(=O)NCCOC)CC([O-])=O
InChI InChI=1S/C20H37N5O10.Gd/c1-34-9-3-21-16(26)11-24(14-19(30)31)7-5-23(13-18(28)29)6-8-25(15-20(32)33)12-17(27)22-4-10-35-2;/h3-15H2,1-2H3,(H,21,26)(H,22,27)(H,28,29)(H,30,31)(H,32,33);/q;+3/p-3^Y Key:HBEAOBRDTOXWRZ-UHFFFAOYSA-K^Y
^NY (what is this?)

Gadoversetamide is a gadolinium-based MRI contrast agent, particularly for imaging of the brain, spine and liver. It is marketed under the trade name OptiMARK.